To this end, CRABP1 signalosomes provide pharmacological targets in diseases such as neurodegeneration, thyroid dysfunction, heart failure, obesity and immune functions. This evidence concerns the gene CRABP1 and obesity due to melanocortin 4 receptor deficiency.